In contrast to our hypothesis we showed that COPD is not associated with the presence of KRAS mutations in lung cancer, whereas presence of EGFR mutations was more frequent in non-COPD as compared to COPD lung cancer patients, after correcting for sex and smoking. Here, EGFR is linked to lung carcinoma.